Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease

Tissue Antigens

Volumn 77, Issue 6, 2011, Pages 554-561

  Pollock, R ^a   Chandran, V ^a   Barrett, J ^b   Eder, L ^a   Pellett, F ^a   Yao, C ^a   Lino, M ^a   Shanmugarajah, S ^a   Farewell, V T ^b   Gladman, D D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Human leucocyte antigens; Major histocompatibility complex class I chain related A; Psoriasis; Psoriatic arthritis

Indexed keywords

HLA B ANTIGEN; HLA C ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE PREDISPOSITION; EVIDENCE BASED PRACTICE; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; JOINT EXAMINATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN RELATED A GENE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SKIN EXAMINATION; UNIVARIATE ANALYSIS; VALIDATION PROCESS;

ADOLESCENT; ADULT; ALLELES; ARTHRITIS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B ANTIGENS; HLA-C ANTIGENS; HOMOZYGOTE; HUMANS; JOINTS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PSORIASIS; SKIN;

EID: 79956131426     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01670.x     Document Type: Article

References (40)

1. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005: 64 (Suppl 2): 18-23.
2. Gladman DD. Psoriatic arthritis. In: Harris ED, Sledge CB, Ruddy S, Firestein GS, Sergent JS, eds. Kelley's Textbook of Rheumatology, 7th edn. Philadelphia: W.B. Saunders Co., 2005, 1155-64.
3. Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol 2003: 4: 441-7.
4. Reich K, Krüger K, Mössner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009: 160: 1040-7.
5. Radtke M, Reich K, Blome C, Rustenbach S, Augustin M. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 2009: 23: 683-91.
6. Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P. Genetics of psoriasis and psoriatic arthritis: update and future direction. J Rheumatol 2008: 35: 1449-53.
7. Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010: 34: J314-21.
8. Feng BJ, Sun LD, Soltani-Arabshahi R et al. Multiple loci within the major histocompatibility complex confer risk of psoriasis. PLoS Genet 2009: 5: e1000606.
9. Ozawa A, Miyahara M, Sugai J et al. HLA class I and II alleles and susceptibility to generalized pustular psoriasis: significant associations with HLA-Cw1 and HLA-DQB1*0303. J Dermatol 1998: 25: 573-81.
10. Henseler T. Genetics of psoriasis. Arch Dermatol Res 1998: 290: 463-76.
11. Gladman DD, Anhorn KA, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol 1986: 13: 586-92.
12. Nair RP, Duffin KC, Helms C et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009: 41: 199-204.
13. Robinson J, Waller MJ, Parham P et al. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 2003: 31: 311-4.
14. Cheng LG, Zhang SZ, Xiao CY et al. The A5.1 allele of the major histocompability complex class I chain-related gene A is associated with psoriasis vulgaris in Chinese. Br J Dermatol 2000: 143: 238-41.
15. Choi HB, Han H, Youn JI, Kim TY, Kim TG. MICA 5.1 allele is a susceptibility marker for psoriasis in the Korean population. Tissue Antigens 2000: 56: 548-50.
16. Romphruk AV, Romphruk A, Choonhakarn C, Puapairoj C, Inoko H, Leelayuwat C. Major histocompabitility complex class I chain-related gene A in Thai psoriasis patients: MICA association as part of human leukocyte antigen-B-Cw haplotypes. Tissue Antigens 2004: 63: 547-54.
17. Mameli A, Cauli A, Taccari E et al. Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study. Clin Exp Rheumatol 2008: 26: 649-52.
18. Fojtikova M, Stolfa J, Novota P, Cejková P, Dostál C, Cerná M. HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population. Rheumatol Int 2009: 29: 1293-9.
19. Gonzalez S, Martinez-Borra J, Torre-Alonso JC et al. The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum 1999: 42: 1010-6.
20. Gonzalez S, Brautbar C, Martinez-Borra J et al. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum Immunol 2001: 62: 632-8.
21. Gonzalez S, Martinez-Borra J, Lopez-Vasquez A, García-Fernández S, Torre-Alonso JC, López-Larrea C. MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. J Rheumatol 2002: 29: 973-8.
22. Grubic Z, Petric P, Eeeuk-Jelicic E et al. The MICA-A4 triplet repeats polymorphism in the transmembrane region confers additional risk for development of psoriatic arthritis in the Croatian population. Eur J Immunogenet 2004: 31: 93-8.
23. Taylor W, Gladman D, Helliwell P et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006: 54: 2665-73.
24. Rees MT, Downing J, Darke C. A typing system for the major histocompatibility complex class I chain related genes A and B using polymerase chain reaction with sequence-specific primers. Genet Test 2005: 9: 93-110.
25. Ahmad T, Marshall SE, Mulcahy-Hawes K et al. High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility. Tissue Antigens 2002: 60: 164-79.
26. UCLA Immunogenetics Center. International MICA Exchange (MICA Exchange Summary) [Internet]. 2005 (updated 4 August 2010; cited 2 December 2010).
27. Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: Tissue Antigens 2003: 61: 403-7.
28. Eagle RA, Jafferji I, Barrow AD. Beyond stressed self: evidence for NKG2D ligand expression on healthy cells. Curr Immunol Rev 2009: 5: 22-34.
29. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gamma delta T cells. Science 1998: 279: 1737-40.
30. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999: 285: 727-9.
31. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001: 2: 255-60.
32. Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A 2001: 98: 11521-6.
33. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001: 413: 165-71.
34. Watzl C. The NKG2D receptor and its ligands-recognition beyond the "missing self"? Microbes Infect 2003: 5: 31-7.
35. Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 2008: 67: 672-6.
36. Spadaro A, Scrivo R, Moretti T et al. Natural killer cells and gamma/delta T cells in synovial fluid and peripheral blood of patients with psoriatic arthritis. Clin Exp Rheumatol 2004: 22: 389-94.
37. Costello P, Bresnihan B, O'Farrelly C, FitzGerald O. Predominance of CD8+ T lymphocytes in psoriatic arthritis. J Rheumatol 1999: 26: 1117-24.
38. Ho PY, Barton A, Worthington J et al. Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis 2008: 67: 677-82.
39. Fan X, Yang S, Sun LD et al. Comparison of clinical features of HLA-Cw*0602-positive and -negative psoriasis patients in a Han Chinese population. Acta Derm Venereol 2007: 87: 335-40.
40. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009: 61: 233-9. Erratum in: Arthritis Rheum 2010: 62: 574.